The team was formed at a brainstorming session hosted by the iHub at Brigham and Women’s Hospital designed to help clinicians and researchers bring their ideas into reality. Additional collaborators include experienced radiologists, oncologists, neurologists and neurosurgeons at Brigham and Women’s Hospital and Massachusetts General Hospital.
Our mission is to revolutionize neuroimaging through groundbreaking technology. We are committed to providing cutting-edge software solutions that enhance the accuracy, accessibility, and clinical utility of MRS data, ultimately empowering clinicians and researchers to make informed decisions for better patient care.
Our goal is to put the power of MRS into the hands of clinicians and researchers worldwide, making the virtual biopsy a reality. By combining our expertise in MRS with innovative visualizations, we strive to transform complex neuroimaging data into clear, actionable insights. BrainSpec is dedicated to pushing the boundaries of MRS research and driving advancements in the field of neuroscience, all with the overarching goal of improving the lives of individuals affected by neurological conditions.
BrainSpec was born at the intersection of clinical practice and academic research at some of the world’s leading medical institutions.
Every feature we build is grounded in peer-reviewed science. Our platform is FDA-cleared because we hold ourselves to the highest standards of clinical validation.
MRS shouldn’t require a PhD to interpret. We make brain chemistry data accessible to every clinician from community hospitals to world-class research centers.
Behind every scan is a patient. We’re driven by the knowledge that earlier, more accurate diagnoses lead to better outcomes for people facing neurological challenges.